Qlucore

Qlucore

Lund, Sweden· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $800K

Overview

Qlucore is a private, revenue-generating diagnostics and software company based in Lund, Sweden, specializing in AI/machine learning-powered bioinformatics tools. The company's primary offerings include Qlucore Omics Explorer for research, Qlucore Insights for disease subtyping, and the IVDR-certified Qlucore Diagnostics for pediatric leukemia. By focusing on intuitive, visualization-driven analysis, Qlucore aims to bridge the gap between complex genomic data and practical application in both research and clinical settings, with a particular emphasis on advancing precision medicine and cancer diagnostics.

Oncology

Technology Platform

Proprietary visualization-based software engine for interactive statistical analysis and exploration of multi-omics data (e.g., RNA-seq, proteomics, qPCR). Features dynamic visualization, real-time filtering, and supports custom R scripting. Platform underpins both research (RUO) and IVDR-certified clinical diagnostic tools.

Funding History

2
Total raised:$800K
Grant$300K
Seed$500K

Opportunities

The rapid growth of multi-omics data in precision medicine and biomarker discovery, particularly in proteomics, creates strong demand for user-friendly analysis tools.
The successful IVDR certification for leukemia diagnostics provides a template to expand into other cancer types and develop companion diagnostics in partnership with pharmaceutical companies.

Risk Factors

Operating in the highly regulated IVDR landscape imposes significant compliance costs and risks of regulatory setbacks.
The company faces intense competition from larger bioinformatics firms and open-source tools, risking market share.
Clinical adoption of new diagnostic software can be slow, challenging commercial execution.

Competitive Landscape

Qlucore competes in the bioinformatics software market against large commercial suites (e.g., Qiagen CLC, Partek Flow, Thermo Fisher), open-source platforms (R/Bioconductor), and other visualization-focused startups. In clinical diagnostics, it competes with established diagnostic companies and laboratory-developed test (LDT) workflows. Its key differentiation is its emphasis on intuitive, interactive visualization for non-bioinformaticians.